Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fish and Richardson
Boehringer Ingelheim
Julphar
Daiichi Sankyo
Medtronic

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,300,669

« Back to Dashboard

Which drugs does patent 7,300,669 protect, and when does it expire?

Patent 7,300,669 protects CUTIVATE and is included in one NDA.

This patent has seventeen patent family members in fifteen countries.

Summary for Patent: 7,300,669
Title:Fluticasone lotion having improved vasoconstrictor activity
Abstract:A fluticasone lotion having improved vasoconstrictor and anti-inflammatory activity and higher than expected potency. The fluticasone lotion contains 0.05 weight percent fluticasone propionate and an oil-in-water vehicle that includes excipients. The fluticasone lotion is unexpectedly efficacious while exhibiting an improved safety profile.
Inventor(s): Dow; Gordon J. (Petaluma, CA), Johnson; Keith Arthur (Durham, NC), Kelly; Frances Furr (Durham, NC), Lathrop; Robert William (Fort Collins, CO), Rajagopalan; Rukmini (Durham, NC)
Assignee: Altana Inc. (Melville, NY)
Application Number:10/800,840
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,300,669
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,300,669
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;

Drugs Protected by US Patent 7,300,669

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Fougera Pharms CUTIVATE fluticasone propionate LOTION;TOPICAL 021152-001 Mar 31, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y RELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF ATOPIC DERMATITIS IN PATIENTS ONE YEAR OF AGE OR OLDER ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 7,300,669

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 6352499 ➤ Sign Up
Australia 754480 ➤ Sign Up
Brazil 9914703 ➤ Sign Up
Canada 2347109 ➤ Sign Up
China 1176659 ➤ Sign Up
China 1326350 ➤ Sign Up
Czech Republic 20011419 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
UBS
Express Scripts
Moodys
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.